DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer

Abstract

Here, mass spectrometry (MS) based targeted proteomic methods such as selected reaction monitoring (SRM) are becoming the method of choice for preclinical verification of candidate protein biomarkers. The Clinical Proteomic Tumor Analysis Consortium (CPTAC) of the National Cancer Institute has investigated the standardization and analytical validation of the SRM assays and demonstrated robust analytical performance on different instruments across different laboratories. An Assay Portal has also been established by CPTAC to provide the research community a resource consisting of large set of targeted MS-based assays, and a depository to share assays publicly, providing that assays meet the guidelines proposed by CPTAC. Herein, we report 98 SRM assays covering 70 candidate protein biomarkers previously reported as associated with ovarian cancer that have been thoroughly characterized according to the CPTAC Assay Characterization Guidance Document. The experiments, methods and results for characterizing these SRM assays for their MS response, repeatability, selectivity, stability, and reproducible detection of endogenous analytes are described in detail.

Authors:
 [1];  [1];  [1];  [1];  [1];  [2];  [1];  [1]; ORCiD logo [1]; ORCiD logo [1];  [1];  [1]
  1. Biological Sciences Div., Richland, WA (United States)
  2. Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Publication Date:
Research Org.:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1375373
Report Number(s):
PNNL-SA-122408
Journal ID: ISSN 2052-4463; 48666; 453040220
Grant/Contract Number:  
AC05-76RL01830
Resource Type:
Accepted Manuscript
Journal Name:
Scientific Data
Additional Journal Information:
Journal Volume: 4; Journal ID: ISSN 2052-4463
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; Environmental Molecular Sciences Laboratory

Citation Formats

Song, Ehwang, Gao, Yuqian, Wu, Chaochao, Shi, Tujin, Nie, Song, Fillmore, Thomas L., Schepmoes, Athena A., Gritsenko, Marina A., Qian, Wei -Jun, Smith, Richard D., Rodland, Karin D., and Liu, Tao. Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer. United States: N. p., 2017. Web. doi:10.1038/sdata.2017.91.
Song, Ehwang, Gao, Yuqian, Wu, Chaochao, Shi, Tujin, Nie, Song, Fillmore, Thomas L., Schepmoes, Athena A., Gritsenko, Marina A., Qian, Wei -Jun, Smith, Richard D., Rodland, Karin D., & Liu, Tao. Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer. United States. https://doi.org/10.1038/sdata.2017.91
Song, Ehwang, Gao, Yuqian, Wu, Chaochao, Shi, Tujin, Nie, Song, Fillmore, Thomas L., Schepmoes, Athena A., Gritsenko, Marina A., Qian, Wei -Jun, Smith, Richard D., Rodland, Karin D., and Liu, Tao. Wed . "Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer". United States. https://doi.org/10.1038/sdata.2017.91. https://www.osti.gov/servlets/purl/1375373.
@article{osti_1375373,
title = {Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer},
author = {Song, Ehwang and Gao, Yuqian and Wu, Chaochao and Shi, Tujin and Nie, Song and Fillmore, Thomas L. and Schepmoes, Athena A. and Gritsenko, Marina A. and Qian, Wei -Jun and Smith, Richard D. and Rodland, Karin D. and Liu, Tao},
abstractNote = {Here, mass spectrometry (MS) based targeted proteomic methods such as selected reaction monitoring (SRM) are becoming the method of choice for preclinical verification of candidate protein biomarkers. The Clinical Proteomic Tumor Analysis Consortium (CPTAC) of the National Cancer Institute has investigated the standardization and analytical validation of the SRM assays and demonstrated robust analytical performance on different instruments across different laboratories. An Assay Portal has also been established by CPTAC to provide the research community a resource consisting of large set of targeted MS-based assays, and a depository to share assays publicly, providing that assays meet the guidelines proposed by CPTAC. Herein, we report 98 SRM assays covering 70 candidate protein biomarkers previously reported as associated with ovarian cancer that have been thoroughly characterized according to the CPTAC Assay Characterization Guidance Document. The experiments, methods and results for characterizing these SRM assays for their MS response, repeatability, selectivity, stability, and reproducible detection of endogenous analytes are described in detail.},
doi = {10.1038/sdata.2017.91},
journal = {Scientific Data},
number = ,
volume = 4,
place = {United States},
year = {Wed Jul 19 00:00:00 EDT 2017},
month = {Wed Jul 19 00:00:00 EDT 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 21 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows
journal, March 2008

  • Deutsch, Eric W.; Lam, Henry; Aebersold, Ruedi
  • EMBO reports, Vol. 9, Issue 5
  • DOI: 10.1038/embor.2008.56

Repeatability and Reproducibility in Proteomic Identifications by Liquid Chromatography−Tandem Mass Spectrometry
journal, February 2010

  • Tabb, David L.; Vega-Montoto, Lorenzo; Rudnick, Paul A.
  • Journal of Proteome Research, Vol. 9, Issue 2
  • DOI: 10.1021/pr9006365

Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests
journal, August 2012


Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays
book, January 2016


The CPTAC Data Portal: A Resource for Cancer Proteomics Research
journal, May 2015

  • Edwards, Nathan J.; Oberti, Mauricio; Thangudu, Ratna R.
  • Journal of Proteome Research, Vol. 14, Issue 6
  • DOI: 10.1021/pr501254j

A List of Candidate Cancer Biomarkers for Targeted Proteomics
journal, January 2006


Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome
journal, July 2016


Multiplexed panel of precisely quantified salivary proteins for biomarker assessment
journal, October 2016

  • Percy, Andrew J.; Hardie, Darryl B.; Jardim, Armando
  • PROTEOMICS, Vol. 17, Issue 6
  • DOI: 10.1002/pmic.201600230

High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics
journal, August 2015

  • Humphrey, Sean J.; Azimifar, S. Babak; Mann, Matthias
  • Nature Biotechnology, Vol. 33, Issue 9
  • DOI: 10.1038/nbt.3327

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
journal, June 2009

  • Addona, Terri A.; Abbatiello, Susan E.; Schilling, Birgit
  • Nature Biotechnology, Vol. 27, Issue 7
  • DOI: 10.1038/nbt.1546

Abundance-based Classifier for the Prediction of Mass Spectrometric Peptide Detectability Upon Enrichment (PPA)
journal, December 2014

  • Muntel, Jan; Boswell, Sarah A.; Tang, Shaojun
  • Molecular & Cellular Proteomics, Vol. 14, Issue 2
  • DOI: 10.1074/mcp.M114.044321

The Human Plasma Proteome: History, Character, and Diagnostic Prospects
journal, October 2002


CPTAC Assay Portal: a repository of targeted proteomic assays
journal, June 2014

  • Whiteaker, Jeffrey R.; Halusa, Goran N.; Hoofnagle, Andrew N.
  • Nature Methods, Vol. 11, Issue 7
  • DOI: 10.1038/nmeth.3002

Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressiveness
journal, May 2017

  • Procházková, Iva; Lenčo, Juraj; Fučíková, Alena
  • Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Vol. 1865, Issue 5
  • DOI: 10.1016/j.bbapap.2017.02.012

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
journal, February 2010


Prognostic Value of Proliferative Activity of Ovarian Carcinoma as Revealed by PCNA and AgNOR Analyses
journal, April 1997

  • Ghazizadeh, Mohammad; Sasaki, Yoshihiro; Araki, Tsutomu
  • American Journal of Clinical Pathology, Vol. 107, Issue 4
  • DOI: 10.1093/ajcp/107.4.451

Targeted Quantitation of Proteins by Mass Spectrometry
journal, March 2013

  • Liebler, Daniel C.; Zimmerman, Lisa J.
  • Biochemistry, Vol. 52, Issue 22
  • DOI: 10.1021/bi400110b

TANDEM: matching proteins with tandem mass spectra
journal, February 2004


Status of Large-scale Analysis of Post-translational Modifications by Mass Spectrometry
journal, November 2013


Towards identification of true cancer biomarkers
journal, September 2014


CONSeQuence: Prediction of Reference Peptides for Absolute Quantitative Proteomics Using Consensus Machine Learning Approaches
journal, August 2011

  • Eyers, Claire E.; Lawless, Craig; Wedge, David C.
  • Molecular & Cellular Proteomics, Vol. 10, Issue 11
  • DOI: 10.1074/mcp.M110.003384

Proliferating cell nuclear antigen (PCNA) immunostaining - a prognostic factor in ovarian cancer?
journal, February 1995

  • Thomas, H.; Nasim, Mm; Sarraf, Ce
  • British Journal of Cancer, Vol. 71, Issue 2
  • DOI: 10.1038/bjc.1995.72

EVA: Exome Variation Analyzer, an efficient and versatile tool for filtering strategies in medical genomics
journal, January 2012


Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays
journal, January 2016


Advances in targeted proteomics and applications to biomedical research
journal, August 2016


Peak areas of individual measurements
dataset, January 2017


A draft map of the human proteome
journal, May 2014

  • Kim, Min-Sik; Pinto, Sneha M.; Getnet, Derese
  • Nature, Vol. 509, Issue 7502
  • DOI: 10.1038/nature13302

Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
journal, May 2012

  • Picotti, Paola; Aebersold, Ruedi
  • Nature Methods, Vol. 9, Issue 6
  • DOI: 10.1038/nmeth.2015

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
journal, July 2016


Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach
journal, January 2014

  • Carr, Steven A.; Abbatiello, Susan E.; Ackermann, Bradley L.
  • Molecular & Cellular Proteomics, Vol. 13, Issue 3
  • DOI: 10.1074/mcp.M113.036095

Linking genome and proteome by mass spectrometry: Large-scale identification of yeast proteins from two dimensional gels
journal, December 1996

  • Shevchenko, A.; Jensen, O. N.; Podtelejnikov, A. V.
  • Proceedings of the National Academy of Sciences, Vol. 93, Issue 25
  • DOI: 10.1073/pnas.93.25.14440

High-throughput generation of selected reaction-monitoring assays for proteins and proteomes
journal, December 2009

  • Picotti, Paola; Rinner, Oliver; Stallmach, Robert
  • Nature Methods, Vol. 7, Issue 1
  • DOI: 10.1038/nmeth.1408

Limits for qualitative detection and quantitative determination. Application to radiochemistry
journal, March 1968


Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum
journal, September 2012

  • Shi, T.; Fillmore, T. L.; Sun, X.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 38
  • DOI: 10.1073/pnas.1204366109

Interlaboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured by Mass Spectrometry
journal, March 2014


Mass-spectrometry-based draft of the human proteome
journal, May 2014

  • Wilhelm, Mathias; Schlegl, Judith; Hahne, Hannes
  • Nature, Vol. 509, Issue 7502
  • DOI: 10.1038/nature13319

Selected reaction monitoring for quantitative proteomics: a tutorial
journal, January 2008

  • Lange, Vinzenz; Picotti, Paola; Domon, Bruno
  • Molecular Systems Biology, Vol. 4, Issue 1
  • DOI: 10.1038/msb.2008.61

Proliferating cell nuclear antigen (PCNA): a dancer with many partners
journal, August 2003


Evaluated data
dataset, January 2017


Space–time wiring specificity supports direction selectivity in the retina
journal, May 2014

  • Kim, Jinseop S.; Greene, Matthew J.; Zlateski, Aleksandar
  • Nature, Vol. 509, Issue 7500
  • DOI: 10.1038/nature13240

Experimental information
dataset, January 2017


The evolving role of mass spectrometry in cancer biomarker discovery
journal, June 2009

  • Wang, Pei; Whiteaker, Jeffrey R.; Paulovich, Amanda G.
  • Cancer Biology & Therapy, Vol. 8, Issue 12
  • DOI: 10.4161/cbt.8.12.8634

PCNA: a silent housekeeper or a potential therapeutic target?
journal, April 2014


Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics
journal, November 2012


Variable blood processing procedures contribute to plasma proteomic variability
journal, January 2021


Evaluated data
dataset, January 2017


Selected reaction monitoring for quantitative proteomics: a tutorial
text, January 2008


Proliferating cell nuclear antigen (PCNA): a dancer with many partners.
text, January 2003


Experimental information
dataset, January 2017


Experimental information
dataset, January 2017


Evaluated Data
dataset, January 2017


Experimental information
dataset, January 2017


Peak areas of individual measurements
dataset, January 2017


Advances in targeted proteomics and applications to biomedical research
journal, August 2016


Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressiveness
journal, May 2017

  • Procházková, Iva; Lenčo, Juraj; Fučíková, Alena
  • Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Vol. 1865, Issue 5
  • DOI: 10.1016/j.bbapap.2017.02.012

Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome
journal, July 2016


Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests
journal, August 2012


PCNA: a silent housekeeper or a potential therapeutic target?
journal, April 2014


Targeted Quantitation of Proteins by Mass Spectrometry
journal, March 2013

  • Liebler, Daniel C.; Zimmerman, Lisa J.
  • Biochemistry, Vol. 52, Issue 22
  • DOI: 10.1021/bi400110b

Repeatability and Reproducibility in Proteomic Identifications by Liquid Chromatography−Tandem Mass Spectrometry
journal, February 2010

  • Tabb, David L.; Vega-Montoto, Lorenzo; Rudnick, Paul A.
  • Journal of Proteome Research, Vol. 9, Issue 2
  • DOI: 10.1021/pr9006365

Proliferating cell nuclear antigen (PCNA) immunostaining - a prognostic factor in ovarian cancer?
journal, February 1995

  • Thomas, H.; Nasim, Mm; Sarraf, Ce
  • British Journal of Cancer, Vol. 71, Issue 2
  • DOI: 10.1038/bjc.1995.72

PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows
journal, March 2008

  • Deutsch, Eric W.; Lam, Henry; Aebersold, Ruedi
  • EMBO reports, Vol. 9, Issue 5
  • DOI: 10.1038/embor.2008.56

Selected reaction monitoring for quantitative proteomics: a tutorial
journal, January 2008

  • Lange, Vinzenz; Picotti, Paola; Domon, Bruno
  • Molecular Systems Biology, Vol. 4, Issue 1
  • DOI: 10.1038/msb.2008.61

A draft map of the human proteome
journal, May 2014

  • Kim, Min-Sik; Pinto, Sneha M.; Getnet, Derese
  • Nature, Vol. 509, Issue 7502
  • DOI: 10.1038/nature13302

High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics
journal, August 2015

  • Humphrey, Sean J.; Azimifar, S. Babak; Mann, Matthias
  • Nature Biotechnology, Vol. 33, Issue 9
  • DOI: 10.1038/nbt.3327

Biomarker validation by targeted mass spectrometry
journal, July 2009

  • McIntosh, Martin; Fitzgibbon, Matthew
  • Nature Biotechnology, Vol. 27, Issue 7
  • DOI: 10.1038/nbt0709-622

Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
journal, May 2012

  • Picotti, Paola; Aebersold, Ruedi
  • Nature Methods, Vol. 9, Issue 6
  • DOI: 10.1038/nmeth.2015

CPTAC Assay Portal: a repository of targeted proteomic assays
journal, June 2014

  • Whiteaker, Jeffrey R.; Halusa, Goran N.; Hoofnagle, Andrew N.
  • Nature Methods, Vol. 11, Issue 7
  • DOI: 10.1038/nmeth.3002

The human proteome takes the spotlight
journal, June 2014


Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum
journal, September 2012

  • Shi, T.; Fillmore, T. L.; Sun, X.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 38
  • DOI: 10.1073/pnas.1204366109

Linking genome and proteome by mass spectrometry: Large-scale identification of yeast proteins from two dimensional gels
journal, December 1996

  • Shevchenko, A.; Jensen, O. N.; Podtelejnikov, A. V.
  • Proceedings of the National Academy of Sciences, Vol. 93, Issue 25
  • DOI: 10.1073/pnas.93.25.14440

Prognostic Value of Proliferative Activity of Ovarian Carcinoma as Revealed by PCNA and AgNOR Analyses
journal, April 1997

  • Ghazizadeh, Mohammad; Sasaki, Yoshihiro; Araki, Tsutomu
  • American Journal of Clinical Pathology, Vol. 107, Issue 4
  • DOI: 10.1093/ajcp/107.4.451

TANDEM: matching proteins with tandem mass spectra
journal, February 2004


Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
journal, February 2010


Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium
journal, October 2013


Towards identification of true cancer biomarkers
journal, September 2014


Interlaboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured by Mass Spectrometry
journal, March 2014


Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays
journal, January 2016


The evolving role of mass spectrometry in cancer biomarker discovery
journal, June 2009

  • Wang, Pei; Whiteaker, Jeffrey R.; Paulovich, Amanda G.
  • Cancer Biology & Therapy, Vol. 8, Issue 12
  • DOI: 10.4161/cbt.8.12.8634

Proliferating cell nuclear antigen (PCNA): a dancer with many partners.
text, January 2003


Works referencing / citing this record:

Clinical potential of mass spectrometry-based proteogenomics
journal, November 2018

  • Zhang, Bing; Whiteaker, Jeffrey R.; Hoofnagle, Andrew N.
  • Nature Reviews Clinical Oncology, Vol. 16, Issue 4
  • DOI: 10.1038/s41571-018-0135-7